Navigation Links
Africa Set to Control Malaria Using Specialized Software

ersity of Bamako in Mali and the Agence Universitaire de la Francophonie in Bamako and in Yaoundé, Cameroon, were able to join the project team based at CERN.

Tom Smith, a professor at the Swiss Tropical Institute, said, "Africa@home and volunteer computing really open up new horizons for us scientifically. We have already done more epidemiological modelling in a few months than we could have achieved on our own computer cluster in a few years."

Malaria is responsible for about a million deaths every year in sub-Saharan Africa and is the single biggest killer of children under five.

CERN, the world's leading laboratory for particle physics, has its headquarters in Geneva. India is one of the countries with observer status at CERN.

(Source: IANS
'"/>




Page: 1 2

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. South Africa dilly-dallying on AIDS situation
3. TB coupled with AIDS soars in Africa
4. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
5. African HIV strains more resistant to anti HIV drugs
6. South Africa Wins landmark case against pharmaceutical giants
7. S. Africa AIDS in death phase
8. Hypertension Drug of Choice for African Americans
9. Over Six Million HIV Infected People In South Africa- Finds A Survey
10. The Kidney Transplantation conspiracy in South Africa
11. Africa Is Not The Only Continent Struggling Against AIDS
Post Your Comments:
(Date:5/12/2008)...Ill., May 12 /PRNewswire-USNewswire/ -- The Americ...ed its policy on castration,and dehorning of cattl...e,for managing pain associated with these procedur..., does not dictate that practitioners use any,part...it provides some,basic recommendations for conside...
(Date:5/12/2008)...assles, Nail Fungus and the Dreaded Summer Yeast I... While the pleasures of summer,abound, warm weathe...omen,aren,t prepared for., Feel your best with th...iding some elusive summertime pitfalls., From The...kin! After,just one hour of exposure, hair begins ...
(Date:5/11/2008)..., May 12 /PRNewswire/ -- Atrium Medical Corporatio...y and precautionary recall of,selected lots of HYD...,Catheters. Limited lots of Atrium heparin-coated ...th heparin found to have been contaminated,with ov... risk associated,with the presence of OSCS in hepa...
(Date:5/11/2008)...ded by the Biotechnology and Biological Sciences R...ctive way to investigate important aspects of huma... The Open University, Dr Lynne Cox and Dr Robert S... means flies can now be used to study the effects ... the journal Aging Cell, the researchers demonstra...
Breaking Medicine News(10 mins):Health News:Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain 2Health News:A Woman's Summertime Guide to Healthy Living From Head-to-Toe 2Health News:A Woman's Summertime Guide to Healthy Living From Head-to-Toe 3Health News:Atrium Initiates Voluntary Recall Action Regarding HYDRAGLIDE(TM) Brand Heparin-Coated Thoracic Drainage Catheters Used for Autotransfusion During Cardiopulmonary Bypass Surgery 2Health News:Human aging gene found in flies 2
...t helping adolescents manage their emotions is jus...on the practical side of safe sex// in order to pr...s. According to the Centers for Disease Control (...rently account for fifty percent of new HIV infect...
...Guillermo Caravotta, whose AIDS documentary "Secon...ng more from the stigma attached// to the disease ...V positive people, second only to South Africa. Ho...ssociated with this disease are the real enemies, ...
...neagles Hospital has opened their hemato-oncology ...increasing number of cancer patients// pouring in ...alty unit, opened Tuesday, will have all the state...atment for different types of hemato oncological d...
...Scotland have demanded a commitment for more fundi...nt. A recent review of the NHS Wheelchair// and Se...bled to ?30m a year. But the Scottish Executive ha... According to Lewis Macdonald, the Deputy Health M...
Other Medicine News:Health News:Managing Emotions to Prevent HIV 2Health News:Doctor's AIDS Documentary Focus on Stigma and Discrimination 2
(Date:5/9/2008)...le in national effort probing for,answers, By J...list, Pennsylvania Game Commission, NOTE: Phot...e from the,Game Commission,s website (http://www....", HARRISBURG, Pa., May 7 /PRNewswire-USNewswir...tself on a new frontier: it is working with severa...
(Date:5/9/2008)...ewswire/ -- Many strong acting pain,medications ha...ea and,vomiting with short-term use, and constipat...ad patients to discontinue treatment, adding addit...ans. The novel investigational,medication tapentad...in,relief for patients with fewer gastrointestinal...
(Date:5/9/2008)...Call/ -- Ardea Biosciences, Inc.,(Nasdaq: RDEA ),...t of,small- molecule therapeutics for the treatmen...ing gout, today announced that John W. Beck,has be...erations and Chief,Financial Officer effective May...ors shortly thereafter. The Company also reported ...
(Date:5/8/2008)...work Completes 13 Phase-I Clinical Trials; Repor...ent, EL SEGUNDO, Calif., May 8 /- Da...ical trial research service business specializing,...lopment for FDA approval,reports it completed 13 ...,active trials in late stage drug development-a co...
Breaking Medicine Technology:White Nose Syndrome: Is Pennsylvania Next? 2White Nose Syndrome: Is Pennsylvania Next? 3White Nose Syndrome: Is Pennsylvania Next? 4White Nose Syndrome: Is Pennsylvania Next? 5White Nose Syndrome: Is Pennsylvania Next? 6New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 2New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 3New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6DaVita Clinical Research Completes Record Number of Renal Trials in 2007 2ILC Dover Launches Revolutionary ArmorFlex 28R 29 Pharmaceutical Product Contact Film 5317 1ILC Dover Launches Revolutionary ArmorFlex 28R 29 Pharmaceutical Product Contact Film 5317 2Redsense Medical Receives FDA Approval for Blood Loss Detection Device 5314 1Redsense Medical Receives FDA Approval for Blood Loss Detection Device 5314 2Redsense Medical Receives FDA Approval for Blood Loss Detection Device 5314 3New designer toxins kill Bt resistant insect pests 1670 1New designer toxins kill Bt resistant insect pests 1670 2New designer toxins kill Bt resistant insect pests 1670 3Worlds smallest radio fits in the palm of the hand of an ant 1667 1Worlds smallest radio fits in the palm of the hand of an ant 1667 2Worlds smallest radio fits in the palm of the hand of an ant 1667 3
...nstrates 50% Survival in Valortim-Treated,Animals ...07 - Medarex,Inc. (Nasdaq: MEDX), a leading monoc...rivately held biotechnology company dedicated,to t...y announced,that Valortim, a fully human monoclona...he prevention and treatment of anthrax,infection, ...
...rce Astellas Commitment to Overcoming Critical,Sho...y, April 02, 2007 /PRNewswire/ --Study results,pre...icrobiology,and Infectious Diseases (ECCMID) show ... micafungin, both have the potential,to meet a sig...ospital-acquired infections (HAIs). , Hospital-acq...
Other Medicine Technology:Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 2Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 3Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 4Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 5
Human based assayed sera available in three levels for the control of accuracy and precision for up to 25 analytes
CRP Liquid Conrtols level 3
Therapeutic Drug Calibrator Series
The IRN method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of iron in serum.
Medicine Products: